Trial | NCT00293878  Report issue

Title

Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Effects on Lipids of 12 Weeks of 2 Doses of FM-VP4 in Subjects With Primary Hypercholesterolemia

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    phytosterol ...

  • Study Participants

    150
The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.
Study Started
Nov 30
2005
Last Update
Feb 26
2007
Estimate

Drug Disodium Ascorbyl Phytostanol Phosphate (FM-VP4)

Criteria 

Inclusion Criteria:

Mild to moderate primary hypercholesterolemia
Able to give informed consent and to comply with study procedures (including diet)

Exclusion Criteria:

Homozygous familial hypercholesterolemia
Age <18 or >75 years
Pregnant women or women of child-bearing potential
No Results Posted